APO Research
Talk to an analyst

APO RESEARCH · REPORT

Computer-assisted Drug Design Platform

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Computer-assisted Drug Design Platform Industry Growth and Trends Forecast to 2032

1 May 2026110 pages

Choose your research edition.

Industry ResearchComputer-assisted Drug Design Platform Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Computer-assisted Drug Design Platform Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Computer-assisted Drug Design Platform Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Computer-assisted Drug Design Platform Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Computer-assisted Drug Design Platform Market Analysis and Forecast 2026-2032206 pages · $4,950 USD

Market perspective

According to APO Research, the global Computer-assisted Drug Design Platform market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Computer-assisted Drug Design Platform is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Computer-assisted Drug Design Platform is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Computer-assisted Drug Design Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Computer-assisted Drug Design Platform market include Entelos, Crown Bioscience, Chemical Computing Group, Nimbus Therapeutics, Schrodinger, Dassault Systemes, Genedata, Biognos and Leadscope, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Computer-assisted Drug Design Platform market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Computer-assisted Drug Design Platform market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Computer-assisted Drug Design Platform market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Computer-assisted Drug Design Platform.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Computer-assisted Drug Design Platform market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Computer-assisted Drug Design Platform Market by Company

Entelos

Crown Bioscience

Chemical Computing Group

Nimbus Therapeutics

Schrodinger

Dassault Systemes

Genedata

Biognos

Leadscope

Rhenovia Pharma Limited

Compugen

Certara LP

Prosarix

Simulations Plus

Strand Life Sciences

Computer-assisted Drug Design Platform Segment by Type

Cloud-based

On-premise

Computer-assisted Drug Design Platform Segment by Application

Drug Discovery and Development

Computational Physiological Medicine

Disease Modeling

Medical Imaging

Predictive Analysis of Drug Targets

Computer-assisted Drug Design Platform Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Computer-assisted Drug Design Platform market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Computer-assisted Drug Design Platform and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Computer-assisted Drug Design Platform.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Computer-assisted Drug Design Platform companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Computer-assisted Drug Design Platform Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Computer-assisted Drug Design Platform Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Computer-assisted Drug Design Platform Market Share by Region (2021-2026) Table 4. Global Computer-assisted Drug Design Platform Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Computer-assisted Drug Design Platform Market Share by Region (2027-2032) Table 6. Global Computer-assisted Drug Design Platform Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Computer-assisted Drug Design Platform Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Computer-assisted Drug Design Platform Market Size Share by Type (2021-2026) Table 9. Global Computer-assisted Drug Design Platform Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Computer-assisted Drug Design Platform Market Size Share Forecasted by Type (2027-2032) Table 11. North America Computer-assisted Drug Design Platform Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Computer-assisted Drug Design Platform Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Computer-assisted Drug Design Platform Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Computer-assisted Drug Design Platform Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Computer-assisted Drug Design Platform Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Computer-assisted Drug Design Platform Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Computer-assisted Drug Design Platform Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Computer-assisted Drug Design Platform Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Computer-assisted Drug Design Platform Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Computer-assisted Drug Design Platform Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Computer-assisted Drug Design Platform Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Computer-assisted Drug Design Platform Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Computer-assisted Drug Design Platform Market Size Share by Application (2021-2026) Table 24. Global Computer-assisted Drug Design Platform Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Computer-assisted Drug Design Platform Market Size Share Forecasted by Application (2027-2032) Table 26. North America Computer-assisted Drug Design Platform Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Computer-assisted Drug Design Platform Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Computer-assisted Drug Design Platform Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Computer-assisted Drug Design Platform Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Computer-assisted Drug Design Platform Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Computer-assisted Drug Design Platform Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Computer-assisted Drug Design Platform Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Computer-assisted Drug Design Platform Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Computer-assisted Drug Design Platform Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Computer-assisted Drug Design Platform Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Computer-assisted Drug Design Platform Industry Trends Table 37. Computer-assisted Drug Design Platform Industry Drivers Table 38. Computer-assisted Drug Design Platform Industry Opportunities and Challenges Table 39. Computer-assisted Drug Design Platform Industry Restraints Table 40. Global Computer-assisted Drug Design Platform Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Computer-assisted Drug Design Platform Revenue Market Share by Company (2021-2026) Table 42. Global Computer-assisted Drug Design Platform Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Computer-assisted Drug Design Platform Key Company Headquarters & Area Served Table 44. Global Computer-assisted Drug Design Platform Company, Product Type & Application Table 45. Global Computer-assisted Drug Design Platform Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Computer-assisted Drug Design Platform by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Entelos Company Information Table 49. Entelos Business Overview Table 50. Entelos Computer-assisted Drug Design Platform Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Entelos Computer-assisted Drug Design Platform Product Portfolio Table 52. Entelos Recent Development Table 53. Crown Bioscience Company Information Table 54. Crown Bioscience Business Overview Table 55. Crown Bioscience Computer-assisted Drug Design Platform Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Crown Bioscience Computer-assisted Drug Design Platform Product Portfolio Table 57. Crown Bioscience Recent Development Table 58. Chemical Computing Group Company Information Table 59. Chemical Computing Group Business Overview Table 60. Chemical Computing Group Computer-assisted Drug Design Platform Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Chemical Computing Group Computer-assisted Drug Design Platform Product Portfolio Table 62. Chemical Computing Group Recent Development Table 63. Nimbus Therapeutics Company Information Table 64. Nimbus Therapeutics Business Overview Table 65. Nimbus Therapeutics Computer-assisted Drug Design Platform Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Nimbus Therapeutics Computer-assisted Drug Design Platform Product Portfolio Table 67. Nimbus Therapeutics Recent Development Table 68. Schrodinger Company Information Table 69. Schrodinger Business Overview Table 70. Schrodinger Computer-assisted Drug Design Platform Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Schrodinger Computer-assisted Drug Design Platform Product Portfolio Table 72. Schrodinger Recent Development Table 73. Dassault Systemes Company Information Table 74. Dassault Systemes Business Overview Table 75. Dassault Systemes Computer-assisted Drug Design Platform Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Dassault Systemes Computer-assisted Drug Design Platform Product Portfolio Table 77. Dassault Systemes Recent Development Table 78. Genedata Company Information Table 79. Genedata Business Overview Table 80. Genedata Computer-assisted Drug Design Platform Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Genedata Computer-assisted Drug Design Platform Product Portfolio Table 82. Genedata Recent Development Table 83. Biognos Company Information Table 84. Biognos Business Overview Table 85. Biognos Computer-assisted Drug Design Platform Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Biognos Computer-assisted Drug Design Platform Product Portfolio Table 87. Biognos Recent Development Table 88. Leadscope Company Information Table 89. Leadscope Business Overview Table 90. Leadscope Computer-assisted Drug Design Platform Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Leadscope Computer-assisted Drug Design Platform Product Portfolio Table 92. Leadscope Recent Development Table 93. Rhenovia Pharma Limited Company Information Table 94. Rhenovia Pharma Limited Business Overview Table 95. Rhenovia Pharma Limited Computer-assisted Drug Design Platform Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Rhenovia Pharma Limited Computer-assisted Drug Design Platform Product Portfolio Table 97. Rhenovia Pharma Limited Recent Development Table 98. Compugen Company Information Table 99. Compugen Business Overview Table 100. Compugen Computer-assisted Drug Design Platform Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Compugen Computer-assisted Drug Design Platform Product Portfolio Table 102. Compugen Recent Development Table 103. Certara LP Company Information Table 104. Certara LP Business Overview Table 105. Certara LP Computer-assisted Drug Design Platform Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Certara LP Computer-assisted Drug Design Platform Product Portfolio Table 107. Certara LP Recent Development Table 108. Prosarix Company Information Table 109. Prosarix Business Overview Table 110. Prosarix Computer-assisted Drug Design Platform Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Prosarix Computer-assisted Drug Design Platform Product Portfolio Table 112. Prosarix Recent Development Table 113. Simulations Plus Company Information Table 114. Simulations Plus Business Overview Table 115. Simulations Plus Computer-assisted Drug Design Platform Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Simulations Plus Computer-assisted Drug Design Platform Product Portfolio Table 117. Simulations Plus Recent Development Table 118. Strand Life Sciences Company Information Table 119. Strand Life Sciences Business Overview Table 120. Strand Life Sciences Computer-assisted Drug Design Platform Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Strand Life Sciences Computer-assisted Drug Design Platform Product Portfolio Table 122. Strand Life Sciences Recent Development Table 123. North America Computer-assisted Drug Design Platform Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. North America Computer-assisted Drug Design Platform Market Size by Country (2021-2026) & (US$ Million) Table 125. North America Computer-assisted Drug Design Platform Market Share by Country (2021-2026) Table 126. North America Computer-assisted Drug Design Platform Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. North America Computer-assisted Drug Design Platform Market Share Forecast by Country (2027-2032) Table 128. Europe Computer-assisted Drug Design Platform Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. Europe Computer-assisted Drug Design Platform Market Size by Country (2021-2026) & (US$ Million) Table 130. Europe Computer-assisted Drug Design Platform Market Share by Country (2021-2026) Table 131. Europe Computer-assisted Drug Design Platform Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. Europe Computer-assisted Drug Design Platform Market Share Forecast by Country (2027-2032) Table 133. Asia-Pacific Computer-assisted Drug Design Platform Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Asia-Pacific Computer-assisted Drug Design Platform Market Size by Country (2021-2026) & (US$ Million) Table 135. Asia-Pacific Computer-assisted Drug Design Platform Market Share by Country (2021-2026) Table 136. Asia-Pacific Computer-assisted Drug Design Platform Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Asia-Pacific Computer-assisted Drug Design Platform Market Share Forecast by Country (2027-2032) Table 138. Latin America Computer-assisted Drug Design Platform Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Latin America Computer-assisted Drug Design Platform Market Size by Country (2021-2026) & (US$ Million) Table 140. Latin America Computer-assisted Drug Design Platform Market Share by Country (2021-2026) Table 141. Latin America Computer-assisted Drug Design Platform Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Latin America Computer-assisted Drug Design Platform Market Share Forecast by Country (2027-2032) Table 143. Middle East & Africa Computer-assisted Drug Design Platform Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Middle East & Africa Computer-assisted Drug Design Platform Market Size by Country (2021-2026) & (US$ Million) Table 145. Middle East & Africa Computer-assisted Drug Design Platform Market Share by Country (2021-2026) Table 146. Middle East & Africa Computer-assisted Drug Design Platform Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Middle East & Africa Computer-assisted Drug Design Platform Market Share Forecast by Country (2027-2032) Table 148. Research Programs/Design for This Report Table 149. Authors List of This Report Table 150. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Computer-assisted Drug Design Platform Product Image Figure 3. Global Computer-assisted Drug Design Platform Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Computer-assisted Drug Design Platform Market Size (2021-2032) & (US$ Million) Figure 5. Global Computer-assisted Drug Design Platform Market Share by Region: 2025 VS 2032 Figure 6. Global Computer-assisted Drug Design Platform Market Share by Region (2021-2032) Figure 7. North America Computer-assisted Drug Design Platform Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Computer-assisted Drug Design Platform Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Computer-assisted Drug Design Platform Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Computer-assisted Drug Design Platform Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Computer-assisted Drug Design Platform Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Cloud-based Image Figure 13. Global Cloud-based Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. On-premise Image Figure 15. Global On-premise Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Global Computer-assisted Drug Design Platform Market Size Overview by Type (2021-2032) & (US$ Million) Figure 17. Global Computer-assisted Drug Design Platform Market Share by Type 2025 VS 2032 Figure 18. North America Computer-assisted Drug Design Platform Market Size Share by Type (2021-2032) Figure 19. Europe Computer-assisted Drug Design Platform Market Size Share by Type (2021-2032) Figure 20. Asia-Pacific Computer-assisted Drug Design Platform Market Size Share by Type (2021-2032) Figure 21. Latin America Computer-assisted Drug Design Platform Market Size Share by Type (2021-2032) Figure 22. Middle East and Africa Computer-assisted Drug Design Platform Market Size Share by Type (2021-2032) Figure 23. Drug Discovery and Development Image Figure 24. Global Drug Discovery and Development Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Computational Physiological Medicine Image Figure 26. Global Computational Physiological Medicine Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Disease Modeling Image Figure 28. Global Disease Modeling Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Medical Imaging Image Figure 30. Global Medical Imaging Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Predictive Analysis of Drug Targets Image Figure 32. Global Predictive Analysis of Drug Targets Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Global Computer-assisted Drug Design Platform Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Computer-assisted Drug Design Platform Market Share by Application 2025 VS 2032 Figure 35. North America Computer-assisted Drug Design Platform Market Size Share by Application (2021-2032) Figure 36. Europe Computer-assisted Drug Design Platform Market Size Share by Application (2021-2032) Figure 37. Asia-Pacific Computer-assisted Drug Design Platform Market Size Share by Application (2021-2032) Figure 38. Latin America Computer-assisted Drug Design Platform Market Size Share by Application (2021-2032) Figure 39. Middle East and Africa Computer-assisted Drug Design Platform Market Size Share by Application (2021-2032) Figure 40. Global Top 5 and 10 Computer-assisted Drug Design Platform Players Market Share by Revenue in 2025 Figure 41. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 42. North America Computer-assisted Drug Design Platform Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 43. North America Computer-assisted Drug Design Platform Market Share by Country: 2021 VS 2025 VS 2032 Figure 44. North America Computer-assisted Drug Design Platform Market Share by Country (2021-2032) Figure 45. Europe Computer-assisted Drug Design Platform Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Computer-assisted Drug Design Platform Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Computer-assisted Drug Design Platform Market Share by Country (2021-2032) Figure 48. Asia-Pacific Computer-assisted Drug Design Platform Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 49. Asia-Pacific Computer-assisted Drug Design Platform Market Share by Country: 2021 VS 2025 VS 2032 Figure 50. Asia-Pacific Computer-assisted Drug Design Platform Market Share by Country (2021-2032) Figure 51. Latin America Computer-assisted Drug Design Platform Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Latin America Computer-assisted Drug Design Platform Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Computer-assisted Drug Design Platform Market Share by Country (2021-2032) Figure 54. Middle East & Africa Computer-assisted Drug Design Platform Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Middle East & Africa Computer-assisted Drug Design Platform Market Share by Country: 2021 VS 2025 VS 2032 Figure 56. Middle East & Africa Computer-assisted Drug Design Platform Market Share by Country (2021-2032) Figure 57. Years Considered Figure 58. Research Process Figure 59. Key Executives Interviewed

Scope & coverage.

Types
  • Cloud-based
  • On-premise
Applications
  • Drug Discovery and Development
  • Computational Physiological Medicine
  • Disease Modeling
  • Medical Imaging
  • Predictive Analysis of Drug Targets
Companies covered
  • Entelos
  • Crown Bioscience
  • Chemical Computing Group
  • Nimbus Therapeutics
  • Schrodinger
  • Dassault Systemes
  • Genedata
  • Biognos
  • Leadscope
  • Rhenovia Pharma Limited
  • Compugen
  • Certara LP
  • Prosarix
  • Simulations Plus
  • Strand Life Sciences

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Computer-assisted Drug Design Platform Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Computer-assisted Drug Design Platform Market Size by Region (2021-2032)
  5. 1.4.1 Global Computer-assisted Drug Design Platform Market Size by Region (2021-2026)
  6. 1.4.2 Global Computer-assisted Drug Design Platform Market Size by Region (2027-2032)
  7. 1.5 Key Regions Computer-assisted Drug Design Platform Market Size (2021-2032)
  8. 1.5.1 North America Computer-assisted Drug Design Platform Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Computer-assisted Drug Design Platform Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Computer-assisted Drug Design Platform Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Computer-assisted Drug Design Platform Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Computer-assisted Drug Design Platform Market Size Growth Rate (2021-2032)
2 Computer-assisted Drug Design Platform Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Cloud-based
  3. 2.1.2 On-premise
  4. 2.2 Global Computer-assisted Drug Design Platform Market Size by Type
  5. 2.2.1 Global Computer-assisted Drug Design Platform Market Size Overview by Type (2021-2032)
  6. 2.2.2 Global Computer-assisted Drug Design Platform Historic Market Size Review by Type (2021-2026)
  7. 2.2.3 Global Computer-assisted Drug Design Platform Market Size Forecasted by Type (2027-2032)
  8. 2.3 Global Computer-assisted Drug Design Platform Market Size by Regions
  9. 2.3.1 North America Computer-assisted Drug Design Platform Market Size Breakdown by Type (2021-2026)
  10. 2.3.2 Europe Computer-assisted Drug Design Platform Market Size Breakdown by Type (2021-2026)
  11. 2.3.3 Asia-Pacific Computer-assisted Drug Design Platform Market Size Breakdown by Type (2021-2026)
  12. 2.3.4 South America Computer-assisted Drug Design Platform Market Size Breakdown by Type (2021-2026)
  13. 2.3.5 Middle East and Africa Computer-assisted Drug Design Platform Market Size Breakdown by Type (2021-2026)
3 Computer-assisted Drug Design Platform Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Drug Discovery and Development
  3. 3.1.2 Computational Physiological Medicine
  4. 3.1.3 Disease Modeling
  5. 3.1.4 Medical Imaging
  6. 3.1.5 Predictive Analysis of Drug Targets
  7. 3.2 Global Computer-assisted Drug Design Platform Market Size by Application
  8. 3.2.1 Global Computer-assisted Drug Design Platform Market Size Overview by Application (2021-2032)
  9. 3.2.2 Global Computer-assisted Drug Design Platform Historic Market Size Review by Application (2021-2026)
  10. 3.2.3 Global Computer-assisted Drug Design Platform Market Size Forecasted by Application (2027-2032)
  11. 3.3 Global Computer-assisted Drug Design Platform Market Size by Regions
  12. 3.3.1 North America Computer-assisted Drug Design Platform Market Size Breakdown by Application (2021-2026)
  13. 3.3.2 Europe Computer-assisted Drug Design Platform Market Size Breakdown by Application (2021-2026)
  14. 3.3.3 Asia-Pacific Computer-assisted Drug Design Platform Market Size Breakdown by Application (2021-2026)
  15. 3.3.4 South America Computer-assisted Drug Design Platform Market Size Breakdown by Application (2021-2026)
  16. 3.3.5 Middle East and Africa Computer-assisted Drug Design Platform Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Computer-assisted Drug Design Platform Industry Trends
  2. 4.2 Computer-assisted Drug Design Platform Industry Drivers
  3. 4.3 Computer-assisted Drug Design Platform Industry Opportunities and Challenges
  4. 4.4 Computer-assisted Drug Design Platform Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Computer-assisted Drug Design Platform Revenue (2021-2026)
  2. 5.2 Global Computer-assisted Drug Design Platform Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Computer-assisted Drug Design Platform Key Company Headquarters & Area Served
  4. 5.4 Global Computer-assisted Drug Design Platform Company, Product Type & Application
  5. 5.5 Global Computer-assisted Drug Design Platform Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Computer-assisted Drug Design Platform Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Computer-assisted Drug Design Platform Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Computer-assisted Drug Design Platform Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Entelos
  2. 6.1.1 Entelos Company Information
  3. 6.1.2 Entelos Business Overview
  4. 6.1.3 Entelos Computer-assisted Drug Design Platform Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Entelos Computer-assisted Drug Design Platform Product Portfolio
  6. 6.1.5 Entelos Recent Developments
  7. 6.2 Crown Bioscience
  8. 6.2.1 Crown Bioscience Company Information
  9. 6.2.2 Crown Bioscience Business Overview
  10. 6.2.3 Crown Bioscience Computer-assisted Drug Design Platform Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Crown Bioscience Computer-assisted Drug Design Platform Product Portfolio
  12. 6.2.5 Crown Bioscience Recent Developments
  13. 6.3 Chemical Computing Group
  14. 6.3.1 Chemical Computing Group Company Information
  15. 6.3.2 Chemical Computing Group Business Overview
  16. 6.3.3 Chemical Computing Group Computer-assisted Drug Design Platform Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Chemical Computing Group Computer-assisted Drug Design Platform Product Portfolio
  18. 6.3.5 Chemical Computing Group Recent Developments
  19. 6.4 Nimbus Therapeutics
  20. 6.4.1 Nimbus Therapeutics Company Information
  21. 6.4.2 Nimbus Therapeutics Business Overview
  22. 6.4.3 Nimbus Therapeutics Computer-assisted Drug Design Platform Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Nimbus Therapeutics Computer-assisted Drug Design Platform Product Portfolio
  24. 6.4.5 Nimbus Therapeutics Recent Developments
  25. 6.5 Schrodinger
  26. 6.5.1 Schrodinger Company Information
  27. 6.5.2 Schrodinger Business Overview
  28. 6.5.3 Schrodinger Computer-assisted Drug Design Platform Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Schrodinger Computer-assisted Drug Design Platform Product Portfolio
  30. 6.5.5 Schrodinger Recent Developments
  31. 6.6 Dassault Systemes
  32. 6.6.1 Dassault Systemes Company Information
  33. 6.6.2 Dassault Systemes Business Overview
  34. 6.6.3 Dassault Systemes Computer-assisted Drug Design Platform Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Dassault Systemes Computer-assisted Drug Design Platform Product Portfolio
  36. 6.6.5 Dassault Systemes Recent Developments
  37. 6.7 Genedata
  38. 6.7.1 Genedata Company Information
  39. 6.7.2 Genedata Business Overview
  40. 6.7.3 Genedata Computer-assisted Drug Design Platform Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Genedata Computer-assisted Drug Design Platform Product Portfolio
  42. 6.7.5 Genedata Recent Developments
  43. 6.8 Biognos
  44. 6.8.1 Biognos Company Information
  45. 6.8.2 Biognos Business Overview
  46. 6.8.3 Biognos Computer-assisted Drug Design Platform Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Biognos Computer-assisted Drug Design Platform Product Portfolio
  48. 6.8.5 Biognos Recent Developments
  49. 6.9 Leadscope
  50. 6.9.1 Leadscope Company Information
  51. 6.9.2 Leadscope Business Overview
  52. 6.9.3 Leadscope Computer-assisted Drug Design Platform Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Leadscope Computer-assisted Drug Design Platform Product Portfolio
  54. 6.9.5 Leadscope Recent Developments
  55. 6.10 Rhenovia Pharma Limited
  56. 6.10.1 Rhenovia Pharma Limited Company Information
  57. 6.10.2 Rhenovia Pharma Limited Business Overview
  58. 6.10.3 Rhenovia Pharma Limited Computer-assisted Drug Design Platform Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Rhenovia Pharma Limited Computer-assisted Drug Design Platform Product Portfolio
  60. 6.10.5 Rhenovia Pharma Limited Recent Developments
  61. 6.11 Compugen
  62. 6.11.1 Compugen Company Information
  63. 6.11.2 Compugen Business Overview
  64. 6.11.3 Compugen Computer-assisted Drug Design Platform Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Compugen Computer-assisted Drug Design Platform Product Portfolio
  66. 6.11.5 Compugen Recent Developments
  67. 6.12 Certara LP
  68. 6.12.1 Certara LP Company Information
  69. 6.12.2 Certara LP Business Overview
  70. 6.12.3 Certara LP Computer-assisted Drug Design Platform Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Certara LP Computer-assisted Drug Design Platform Product Portfolio
  72. 6.12.5 Certara LP Recent Developments
  73. 6.13 Prosarix
  74. 6.13.1 Prosarix Company Information
  75. 6.13.2 Prosarix Business Overview
  76. 6.13.3 Prosarix Computer-assisted Drug Design Platform Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Prosarix Computer-assisted Drug Design Platform Product Portfolio
  78. 6.13.5 Prosarix Recent Developments
  79. 6.14 Simulations Plus
  80. 6.14.1 Simulations Plus Company Information
  81. 6.14.2 Simulations Plus Business Overview
  82. 6.14.3 Simulations Plus Computer-assisted Drug Design Platform Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Simulations Plus Computer-assisted Drug Design Platform Product Portfolio
  84. 6.14.5 Simulations Plus Recent Developments
  85. 6.15 Strand Life Sciences
  86. 6.15.1 Strand Life Sciences Company Information
  87. 6.15.2 Strand Life Sciences Business Overview
  88. 6.15.3 Strand Life Sciences Computer-assisted Drug Design Platform Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Strand Life Sciences Computer-assisted Drug Design Platform Product Portfolio
  90. 6.15.5 Strand Life Sciences Recent Developments
7 North America
  1. 7.1 North America Computer-assisted Drug Design Platform Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Computer-assisted Drug Design Platform Market Size by Country (2021-2026)
  3. 7.3 North America Computer-assisted Drug Design Platform Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Computer-assisted Drug Design Platform Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Computer-assisted Drug Design Platform Market Size by Country (2021-2026)
  3. 8.3 Europe Computer-assisted Drug Design Platform Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Computer-assisted Drug Design Platform Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Computer-assisted Drug Design Platform Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Computer-assisted Drug Design Platform Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Computer-assisted Drug Design Platform Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Computer-assisted Drug Design Platform Market Size by Country (2021-2026)
  3. 10.3 South America Computer-assisted Drug Design Platform Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Computer-assisted Drug Design Platform Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Computer-assisted Drug Design Platform Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Computer-assisted Drug Design Platform Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst